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OPEN
ORIGINAL ARTICLE
Electrical stimulation alleviates depressive-like behaviors of
rats: investigation of brain targets and potential mechanisms
LW Lim1,2,3,4,5, J Prickaerts2, G Huguet6, E Kadar6, H Hartung3, T Sharp3 and Y Temel2,4
Deep brain stimulation (DBS) is a promising therapy for patients with refractory depression. However, key questions remain with
regard to which brain target(s) should be used for stimulation, and which mechanisms underlie the therapeutic effects. Here, we
investigated the effect of DBS, with low- and high-frequency stimulation (LFS, HFS), in different brain regions (ventromedial
prefrontal cortex, vmPFC; cingulate cortex, Cg; nucleus accumbens (NAc) core or shell; lateral habenula, LHb; and ventral tegmental
area) on a variety of depressive-like behaviors using rat models. In the naive animal study, we found that HFS of the Cg, vmPFC, NAc
core and LHb reduced anxiety levels and increased motivation for food. In the chronic unpredictable stress model, there was a
robust depressive-like behavioral phenotype. Moreover, vmPFC HFS, in a comparison of all stimulated targets, produced the most
profound antidepressant effects with enhanced hedonia, reduced anxiety and decreased forced-swim immobility. In the following
set of electrophysiological and histochemical experiments designed to unravel some of the underlying mechanisms, we found that
vmPFC HFS evoked a speciﬁc modulation of the serotonergic neurons in the dorsal raphe nucleus (DRN), which have long been
linked to mood. Finally, using a neuronal mapping approach by means of c-Fos expression, we found that vmPFC HFS modulated a
brain circuit linked to the DRN and known to be involved in affect. In conclusion, HFS of the vmPFC produced the most potent
antidepressant effects in naive rats and rats subjected to stress by mechanisms also including the DRN.
Translational Psychiatry (2015) 5, e535; doi:10.1038/tp.2015.24; published online 31 March 2015
INTRODUCTION
Major depression is one of the most common of all psychiatric
disorders, with a life-time prevalence of 16.2% for the United
States1 and 14% for Europe.2 It is ranked as a leading cause of
societal burden among all diseases. Depression can be treated by
antidepressant drugs and/or psychotherapy. In cases with a severe
disease course, electroconvulsive therapy is usually applied.
Nevertheless, ~ 60% of subjects remain clinically refractory,3 and
for these patients, deep brain stimulation (DBS) has been
proposed as an effective/potential treatment.4,5
Recent clinical studies have demonstrated that DBS of the
subgenual anterior cingulate cortex induced striking and sustained
remission of depressive symptoms.6–8 Similarly, DBS of the nucleus
accumbens (NAc), a key region in the reward circuitry, produced
substantial therapeutic effects in patients with major depression.9,10
These effects were also found with DBS of homolog regions in
animal models, namely the ventromedial prefrontal cortex (vmPFC)
and NAc.11–15 Besides these two main targets, other brain areas
have also been explored as candidates for DBS in clinical case
studies including the ventral capsule/ventral striatum16 and the
lateral habenular nucleus (LHb).17 In animal models, these areas
include the LHb,18 and the ventral tegmental area (VTA).19 All of
these regions have a critical role in the regulation of negative
emotions and are interconnected with a wide range of networks,
forming a neurocircuitry for affective disorders.20,21
However, key questions still remain in DBS: (i) Which brain area
results in the most optimal behavioral outcome? (ii) Which
stimulation parameters are the most effective? (iii) Which mechan-
isms underlie the therapeutic effects? Here, we addressed these three
research questions. We performed DBS with low- or high-frequency
stimulation (LFS or HFS) of six different brain areas (vmPFC; cingulate
cortex, Cg; NAc core or shell; LHb; and VTA), which have previously
been identiﬁed in naive animal experiments. For further validation of
these ﬁndings, we tested the stimulation effects that were obtained
from naive animal studies using the chronic unpredictable stress
(CUS) animal model of depression. The behavioral effects on anxiety
response, food motivation, hedonia and forced-swim immobility for
antidepressant activity were assessed. We aimed to cover the various
depressive-like symptoms, mimicking clinical depression as far as
possible.22 In addition to this, the effects of different stimulation
parameters were assessed. To investigate possible mechanisms
involved, we focused on the midbrain 5-HT (5-hydroxytryptamine,
serotonin) system, which has been linked to mood.23,24 We therefore
carried out an in-depth examination of the 5-HT neuronal ﬁring and
morphology in the dorsal raphe nucleus (DRN) in response to DBS,
using both electrophysiological and histochemical approaches. This
choice was also supported by previous ﬁnding showing a profound
effect of DBS on the release of 5-HT in the forebrain.14
MATERIALS AND METHODS
Design of the study
We conducted two studies to investigate the above-mentioned research
questions. In study 1, behavioral experiments were performed on naive
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animals and in the CUS rat model. A battery of behavioral tests was used to
evaluate the effects of DBS with either LFS or HFS. In study 2, since recent
studies have shown that vmPFC HFS is the most effective target for
antidepressant activity with increased hippocampal 5-HT levels,14 we
continued with vmPFC HFS, and performed electrophysiological and
histochemical studies on the DRN 5-HT neurons to further understand the
underlying mechanisms behind antidepressant effects of DBS.
Study 1
Subjects. We used male rats (300–400 g; Sprague Dawley, n= 212, Charles
River, Sulzfeld, Germany), which were housed individually in standard
cages on sawdust bedding in a temperature (~20–22 °C) and humidity (60–
70%) -controlled environment, using 12/12- h reversed dark/light cycle
(lights off at 0800 h). Food and water were available ad libitum. All the
experiments were carried out in accordance with the Animal Experiments
and Ethics Committee of Maastricht University.
Two sets of behavioral experiments were conducted. In the ﬁrst set of
experiments (animals, n= 124), we stimulated the Cg (LFS, n=8; HFS, n= 8),
vmPFC (LFS, n= 10; HFS, n=10), NAc core (LFS, n= 8; HFS, n= 8), NAc shell
(LFS, n= 8; HFS, n= 8), LHb (LFS, n= 8; HFS, n= 8), and VTA (LFS, n= 8; HFS,
n= 8) in naive animals with either LFS or HFS. Sham animals (n= 24) were
implanted in the Cg, vmPFC, NAc core, NAc shell, LHb and VTA (each
group, n=4), but not stimulated. The behavioral battery included the
home-cage emergence test and the open-ﬁeld test to assess changes in
anxiety levels and gross mobility, respectively. The food intake test was
applied to measure motivation for food. The sucrose intake test was used
to evaluate changes in hedonia, and ﬁnally the forced-swim test was used
to assess antidepressant-like activity. In the second set of experiments, the
most effective DBS targets were tested in the CUS rat model, again using
the same behavioral battery. The behavioral sequence of testing for the
two sets of experiments was as follows: home-cage emergence test, open-
ﬁeld test, food intake test, sucrose intake test and ﬁnally the forced-
swim test.
Electrode implantation and stimulation procedures. Surgery was per-
formed as previously described.25,26 Detailed information about the
surgical procedures can be found in the Supplementary Methods. In brief,
a bilateral stimulating electrode was implanted in the Cg (AP: +1.70mm; L:
± 0.60mm; V: − 2.60mm), vmPFC (AP: +2.70 mm; L: ± 0.60mm; V: − 4.60
mm), NAc core (AP: +2.20mm; L: ± 1.50mm; V: − 6.80mm), NAc shell (AP:
+1.70mm; L: ± 0.60mm; V: − 7.20mm), LHb (AP: − 3.80mm; L: ± 0.60mm;
V: − 5.00mm) and VTA (AP: − 6.04mm; L: ± 0.60mm; V: − 8.40mm),
according to the rat brain atlas of Paxinos and Watson.27 After
implantation, animals had a 2-week recovery period.
For DBS, we used a stimulation amplitude of 100 μA on the basis of
previous research,28 of either LFS (10 Hz) or HFS (100 Hz). The pulse width
was set at 100 μs, again on the basis of the results of previous
experiments.29 A World Precision Instruments digital stimulator (DS8000,
WPI, Berlin, Germany) and a stimulus isolator (DLS100, WPI), were used to
deliver the stimuli.
Behavioral battery. During the behavioral tests, animals received either
stimulation (LFS or HFS) or sham stimulation (cables connected but
stimulator turned off). In all the experiments, animals were stimulated for
~ 15min before each behavioral task and this continued for the entire
duration of testing.
Home-cage emergence test: In this test, the home-cage was placed
on a platform and the lid of the home-cage was removed. A grid was
placed over the edge of the home-cage to make it easier for the animal to
leave the home-cage. The experimenters measured the time it took for the
rat to climb out of its cage onto the grid. If the rat did not escape from its
home-cage within 10min, the session was ended, and the rat was given a
score of 600 s.30
Open-ﬁeld test: The open-ﬁeld behavior was conducted in an enclosed
square, clear, Plexiglas box (100× 100× 40 cm), with an open top and a
dark ﬂoor.31 The behavior of each rat was recorded using an automated
system consisting of a camera connected to a computer with the
EthoVision tracking software (EthoVision, Noldus, The Netherlands). Before
testing, the animals were stimulated for 15min and subsequently tested
for 10min in the open-ﬁeld arena. A trial was stopped automatically after
10min and the rat was immediately placed back into its home-cage.
Food intake test: Before testing, the animals were deprived of food and
water for 24 h, and stimulated for 15min before, and then continuously
during the entire procedure. The animals were placed in their individual
home-cage with access to a limited amount of food in a Petri-dish. After
2 h of testing, the total food intake (g) was calculated from the amount of
food consumed.32
Sucrose intake test: One day before the test, the animals were
habituated to drink 1% sucrose solution by exposing them to sucrose
instead of water for 1 h. After a period of 14 h of food and water
deprivation, which started at the beginning of the dark phase, animals
were offered sucrose for 1 h. The sucrose intake was calculated from the
total amount of sucrose solution consumed divided by the weight of the
animal (g per kg).33
Forced-swim test: This test was carried out using a transparent Perspex
cylinder (50 × 20 cm). The cylinder was ﬁlled with tap water (25 ± 1 °C) to a
depth of 30 cm.29,34 Testing was carried out over two consecutive days. In a
pretest session, each rat was placed in the water for 15min. The following
day, the rats were tested in the cylinder containing water for 10min.
Recordings of behavior were taken by a digital camera. The duration of the
following behaviors was timed by observers that were masked to
treatments: ‘immobility’ (no movements or small and infrequent move-
ments performed solely to maintain the nose above the water), ‘swimming’
(active swimming with the forepaws) and ‘climbing’ (scratching of cylinder
walls using both forepaws and hind paws).
The chronic unpredictable stress model. The CUS group (HFS vmPFC,
n= 16; HFS NAc core, n=16; HFS NAc shell, n= 16; HFS LHb, n=16; sham,
n= 16) was exposed to 3 weeks of chronic unpredictable stressors, whereas
operated controls (n=8) were left undisturbed. The CUS sham animals
received similarly to the naive animals, electrode implantations in the
vmPFC, NAc core, NAc shell and LHb (each group, n=4), without
stimulation. The CUS and the control groups (n= 88) were placed in
separate rooms. The stress procedure was performed according to
previous descriptions with some minor modiﬁcations.35,36 Brieﬂy, the
protocol consisted of intermittent illumination every 2 h, housing in mouse
cages, stroboscopic light (2.5 Hz), soiled-cage with 300ml cold water,
paired-housing in dirty cages (with excreta of another rat), food and water
deprivation and a condition with no stressors. During paired-housing, rats
were grouped in pairs with different partners—alternately a resident or an
intruder. All the stressors lasted for 10–14 h. To maintain a low level of
predictability, times and order of the CUS were not ﬁxed, but one always
took place in the morning and the other in the evening. After 3 weeks of
exposure to stress, the stressed and unchallenged control groups were
subjected to behavioral testing. Stress was continued during the entire
period of testing, but always applied after daily behavioral testing.
Study 2
Subjects. For electrophysiology, we used male rats (270–320 g; Sprague–
Dawley, n=12, Harlan Olac, Bicester, UK), which were housed in conditions
similar to those described in Study 1. All experiments were carried out with
approval from the UK Home Ofﬁce Animals (Scientiﬁc Procedures)
Act 1986.
For histochemistry, we used the brains of subjects derived from Study 1
of the CUS experiment to compare differences between vmPFC HFS and
sham animals.
Electrophysiology. Extracellular single-unit recordings of cells in the DRN
were performed, as previously described.37 Detailed information about the
electrophysiology methods used can be found in the Supplementary
Methods. In brief, after 5 min of baseline recording of individual DRN
neurons, DBS with the most effective parameters (frequency: 100 Hz;
amplitude: 100 μA; and pulse width: 100 μs) was performed for 5 min and
recordings continued for a further 5 min after the cessation of the stimulus.
After recording, the same neuron was then subjected to juxtacellular
labeling for postmortem histochemical analysis.
Histochemistry. Before being killed, all animals received 1 h HFS followed
by 1 h interval in their home-cage. Subsequently, the rats were
anesthetized with Nembutal (75mg kg− 1) and perfused transcardially
with 4% paraformaldehyde ﬁxative solution. The brains were cryopro-
tected by overnight 15% sucrose treatment and frozen with CO2. The
brains were cut serially (10 series) on a cryostat (MICROM, Walldorf,
Germany) into 30 μm coronal sections and stored at − 80 °C until stainings
were performed. A standard hematoxylin–eosin (Merck, Darmstadt,
Germany) staining was performed to examine the localization of the
electrode tips and screen for histological damage. We performed
immunohistochemical stainings for c-Fos and 5-HT on the basis of
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previously established methods.38,39 For the staining methods, microscopic
analysis and quantiﬁcation, please refer to the Supplementary Methods.
Statistical analysis. All the data are presented as mean± s.e.m. and
statistical analyses were performed with IBM SPSS Statistics 20 (Armonk,
New York, USA). Normality and homogeneity of variance was performed
using the Kolmogorov–Smirnov test. The data of the behavioral studies
were analyzed using one-way analysis of variance with Bonferroni post hoc
tests for multiple comparisons. Comparisons between CUS-sham and non-
CUS control were performed by two-tailed Student's t-tests. Electrophy-
siological data were analyzed by one-way analysis of variance with
repeated measures. For the data of the histochemical study, we used either
an independent sample t-test or a nonparametric Mann–Whitney U-test, as
appropriate. All P-values o0.05 were considered signiﬁcant.
RESULTS
Electrode localization
Electrodes were traced in the predeﬁned brain targets in ~ 92% of
the cases. The animals with misplacement or detachment of the
electrodes (8% of the cases) in the naive (NAc core HFS, n= 2; NAc
shell HFS, n= 1; LHb LFS, n= 2; LFS VTA, n= 1; sham, n= 5) and CUS
(NAc core HFS, n= 1; NAc shell HFS, n= 3; sham, n= 2) animal
experiments were discarded from data analysis. For representative
ﬁgures and overall electrode positions, see Figure 1. No
histological damage was observed except for the electrode
trajectory.
Overall, the ﬁnal number of rats per group was as follows for
naive (total, n= 113; Cg: LFS, n= 8; HFS, n= 8; vmPFC: LFS, n= 10;
HFS, n= 10; NAc core: LFS, n= 8; HFS, n= 6; NAc shell: LFS, n= 8;
HFS, n= 7; LHb: LFS, n= 6; HFS, n= 8; VTA: LFS, n= 7; HFS, n= 8; and
sham, n= 19) and CUS (total, n= 82; HFS vmPFC, n= 16; HFS NAc
core, n= 15; HFS NAc shell, n= 13; HFS LHb, n= 16; Sham, n= 14;
and control, n= 8) animal experiments.
Study 1
Behavioral effects of LFS and HFS in naive animals. Stimulation of
the vmPFC,11,13,14,40 NAc,12 ventral striatum,16 LHb17,18 and VTA19
has previously been shown to contribute to antidepressant effects.
We set out to determine which brain areas and which stimulation
parameters resulted in the most optimal behavioral outcome
following DBS. Our ﬁndings in the naive animal study show that
HFS of the Cg, vmPFC, NAc core and LHb, but not of the NAc shell
or of the VTA, resulted in a remarkable reduction of the escape
latency time (F(6,59) = 6.415, Po0.001; Figure 2b) in the home-cage
emergence test, and furthermore resulted in a signiﬁcant increase
in food intake (F(6,62) = 8.550, P= 0.001; Figure 3b) as compared
with sham animals. The Bonferroni post hoc tests for multiple
comparisons showed that both LFS and HFS did not affect the
behaviors of naive animals in the open-ﬁeld center zone (LFS: F
(6,50) = 6.220, P= 0.001; HFS: F(6,52) = 2.755, P= 0.021; Figures 2c and
d), sucrose intake (LFS: F(6,58) = 1.028, P=not signiﬁcant (NS); HFS: F
(6,55) = 2.584, P= 0.028; Figures 3c and d), nor any alternations in
the duration of immobility (LFS: F(6,52) = 2.156, P=NS; HFS: F(6,51)
= 3.388, P= 0.007; Figures 3e and f), swimming (LFS: F(6,52) = 1.174,
P=NS; HFS: F(6,51) = 2.059, P=NS; Figures 3g and h) and climbing
(LFS: F(6,52) = 1.419, P=NS; HFS: F(6,51) = 1.792, P=NS; Figures 3i and
j) activity in the forced-swim test. For locomotion behavior, we
tested whether DBS might alter the locomotor activity and
thereby confound the results of the behavioral tests. In the open-
ﬁeld, HFS of the VTA (F(6,55) = 2.537, P= 0.031) increased the motor
parameter of distance moved. No difference was found on the
open-ﬁeld distance moved for LFS (F(6,54) = 3.169, P= 0.010).
In the sham implanted animals, there were no signiﬁcant
differences in the behaviors with respect to the implantation site
(home-cage emergence test, F(5,14) = 0.904, P=NS; open-ﬁeld test,
all variables F(5,9)40.356, P=NS; food intake test, F(5,16) = 1.358,
P=NS; sucrose intake test, F(5,15) = 0.298, P=NS; and forced-swim
immobility test, F(5,13) = 1.408, P=NS), and therefore we pooled all
the animals into one sham group.
For the results of the comparison of the behavioral effects of
DBS compared with the respective individual sham groups in
naive animal experiment, please see Supplementary Table 1.
Summary of the behavior: HFS of the Cg, vmPFC, NAc core and
LHb consistently resulted in reduced anxiety with decreased
escape latency in the home-cage emergence test and increased
motivation for food intake. No signiﬁcance effects were found in
the open-ﬁeld, sucrose intake and forced-swim tests. HFS resulted
in better behavioral outputs than LFS.
Behavioral effects of HFS in the CUS model. To validate our
ﬁndings from the naive animal study, we further tested our
hypothesis that HFS of the vmPFC, NAC core (including NAc shell
for comparison) and LHb on the behaviors of the CUS animal
model. The same ﬁve behavioral paradigms as described for the
previous experiment were again used here. In the CUS animal
model, we found a signiﬁcant phenotype difference for
depressive-like behaviors between sham-CUS and non-CUS
animals. Student t-tests revealed that CUS sham remarkably
increased the escape latency from the home-cage (t16 = 5.726,
Po0.001; Figure 4a), decreased the time spent in the open-ﬁeld
center zone (t17 =− 4.198, P= 0.001; Figure 4b), decreased sucrose
intake (t17 =− 2.766, P= 0.013; Figure 4d), increased immobility (t20
= 6.790, Po0.001; Figure 4e) and decreased swimming time (t17
=− 3.120, P= 0.005; Figure 4f) in the forced-swim test, as
compared with control non-CUS animals. However, no effect
was found for food intake (t15 =− 0.522, P=NS; Figure 4c). In terms
of locomotor activity, no signiﬁcant difference was found for the
open-ﬁeld distance moved (t17 =− 1.499, P=NS) and climbing (t19
=− 0.294, P=NS; Figure 4g) behavior in the forced-swim test.
In the home-cage emergence test, HFS of the vmPFC, NAc core
and LHb reduced the escape latency of rats from their home-cage
(F(5,70) = 9.185, P= 0.001; Figure 4a). Interestingly, HFS of the
vmPFC, but not other DBS targets, resulted in signiﬁcantly
increased time spent by rats in the center zone of the open-
ﬁeld (F(5,70) = 4.222, P= 0.002; Figure 4b) and increased sucrose
consumption substantially (F(5,66) = 12.121, P= 0.001; Figure 4d)
when compared with the CUS sham animals. No behavioral
alternation was found in the motivation for food intake (F(5,64)
= 2.914, P= 0.02; Figure 4c). Strikingly, HFS of the vmPFC and the
LHb signiﬁcantly reduced the immobility time (F(5,76) = 26.077,
Po0.001; Figure 4e). There was also a signiﬁcant effect of
increased swimming time (F(5,75) = 16.091, Po0.001; Figure 4f)
found with vmPFC HFS. No signiﬁcant changes were found in
climbing time (F(5,75) = 1.884, P=NS; Figure 4e). For locomotion
behavior, NAc shell HFS signiﬁcantly increased the distance
moved (F(5,70) = 5.217, Po0.001) in the open-ﬁeld as compared
with the CUS sham.
As for the CUS sham animals, no signiﬁcant differences were
found in the behaviors with respect to the implantation site
(home-cage emergence test, F(3,8) = 0.619, P=NS; open-ﬁeld test,
all variables F(3,9)40.301, P=NS; food intake test, F(3,6) = 0.917,
P=NS; sucrose intake test, F(3,8) = 0.566, P=NS; and forced-swim
immobility test, F(3,10) = 1.227, P=NS). Therefore, all CUS sham
animals were pooled into one sham group.
For the results of the comparison of the behavioral effects of
DBS compared with the respective individual sham groups in CUS
animal experiment, please see Supplementary Table 2.
Summary of the behavior: In the CUS animal model, HFS of the
vmPFC, NAc core and LHb resulted in anxiolytic effects in the
home-cage emergence test. However, in the open-ﬁeld and
sucrose intake tests, vmPFC HFS consistently showed signiﬁcant
reduced anxiety and increased sucrose consumption in a
comparison of all stimulated targets. In the forced-swim test,
HFS of the vmPFC and LHb produced a drastic reduction in the
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duration of immobility. No difference was shown in the food
intake test.
Study 2
As HFS of the vmPFC resulted in the best antidepressant effects
(with reduced anxiety levels in both the home-cage emergence
and open-ﬁeld tests, enhanced hedonia in sucrose intake test and
reduction of forced-swim immobility) in the CUS animal model, we
continued with only HFS of the vmPFC and investigated the 5-HT
neuronal ﬁring and morphology in the DRN. In addition, we also
investigated the neural circuitry inﬂuenced by HFS of the vmPFC
using c-Fos neuronal activation mapping approach in brain
regions that have been implicated in the pathophysiology of
depression in the CUS animal model.
Electrophysiological effects of vmPFC HFS on DRN 5-HT and non-5-
HT neurons. A total of 34 slow- and fast-ﬁring DRN neurons were
recorded (n= 12 rats). Eighteen neurons had typical electrophy-
siological properties of 5-HT neurons: a slow ﬁring rate (0.94 ± 0.1
Hz), regular ﬁring pattern (coefﬁcient of variation, 0.32 ± 0.02) and
a triphasic waveform of wide spike duration (2.03 ± 0.06 ms;
Figure 5c). Sixteen neurons were fast-ﬁring (2.96 ± 1.0 Hz), had an
Figure 1. Schematic illustration of the anatomical placement of stimulating electrode in the vmPFC (a), LHb (b), Cg (c), NAc (d) and the VTA (e).
Photomicrograph of a 30-μm-thick coronal section from the brain of a rat showing the histological veriﬁcation of the electrode location in the
vmPFC (scale bar, 1 mm). The symbol (●) indicates the tips of all electrode localization. cc, corpus callosum; Cg1 and Cg2, cingulate cortex 1
and cingulate cortex 2; D3V, dorsal third ventricle; fmi, forceps minor of corpus callosum; fr, fasciculus retroﬂexus; IF, interfascicular nucleus; IL,
infralimbic; LHb, lateral habenular nucleus; MHb, medial habenular nucleus; M2, secondary motor cortex; NAc core, nucleus accumbens core;
NAc shell, nucleus accumbens shell; PrL, prelimbic; RLi, rostral linear nucleus of the raphe; RPC, parvicellular part of the red nucleus; SNR,
reticular part of the substantia nigra; vmPFC, ventromedial prefrontal cortex; VTA, ventral tegmental area.
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irregular ﬁring pattern (coefﬁcient of variation, 0.86 ± 0.1) and a
shorter spike duration (1.64 ± 0.12 ms). These are considered to be
non-5-HT neurons.
HFS of the vmPFC increased the ﬁring rate in seven putative 5-
HT neurons and decreased it in 11 neurons. The effect was already
present in the ﬁrst 2 min, continued after cessation of HFS and
increased over time (F(3,27) = 5.232, Po0.01; Figures 5a and d). The
activated 5-HT neurons (n= 7) showed a mean increase in the
ﬁring rate during the second minute of 4.92 ± 6.65%, during the
ﬁfth minute of 24.28 ± 8.92% and after 5 min of 40.36 ± 11.81%. In
comparison, the inhibited 5-HT neurons (n= 11, F(3,43) = 4.122,
Po0.01, Figures 5a and f) had a mean decrease of the ﬁring rate
of − 10.98 ± 3.25% and − 12.71 ± 3.21% during the second and ﬁfth
minute of HFS, respectively. After 5 min, the inhibition continued
and was − 15.05 ± 4.72%. No signiﬁcant correlation was found
between baseline ﬁring rate and the magnitude of the excitation
and inhibition in neuronal ﬁring (Figures 5e and g).
HFS of the vmPFC had no statistically signiﬁcant effect on the
ﬁring rates of excited (n= 5 neurons; F(3,19) = 1.504, P= 0.25) and
nonresponding non 5-HT cells (n= 8 neurons; F(3,31) = 0.848,
P= 0.48). However, there was a signiﬁcant effect in the ﬁring rate
of non 5-HT neurons that showed inhibition (n= 3 neurons; F(3,11)
= 7.611, Po0.01) with a mean decrease of the ﬁring rate during
the second minute of − 8.40 ± 2.16%, during the ﬁfth minute of
− 19.27 ± 2.52%, and after 5 min of − 20.04 ± 6.09%.
Histochemical effects of vmPFC HFS on DRN neurons. HFS of the
vmPFC signiﬁcantly increased the number of c-Fos-ir cells in the
median (dorsal raphe dorsal part, DRD (t10 = 2.459, P= 0.034)) and
lateral wings (dorsal raphe ventrolateral part, DRVL (t9 = 9.068,
P= 0.001)) of DRN regions as compared with CUS sham animals,
indicating a modulation of the DRN 5-HT (median part) and non 5-
HT neurons (lateral wings) in response to vmPFC HFS (Figures 6a
and b). No signiﬁcant difference was found in the dorsal raphe
ventral part, DRV (t10 = 0.416, P= 0.686). This is in line with our
electrophysiology data. Further evaluation of the 5-HT-containing
cells revealed that vmPFC HFS signiﬁcantly lowered the optical
density signal in the 5-HT cells of the DRD, DRV and DRVL (all
to − 8.230, Po0.001) as compared with the CUS sham group
(Figures 6c and d). To further characterize the nature of the
investigated cells, qualitative assessment of the immunoﬂuores-
cence double-labeled sections showed co-localization between 5-
HT and c-Fos in the DRD region (Figure 6e).
Effects of vmPFC HFS in the neural circuitry of depressive-like
behavior. Using a neuronal mapping approach, we investigated
the target areas of the DRN 5-HT system in the forebrain (see
Table 1). In the frontal cortex regions, we found enhanced levels of
c-Fos-ir cells in the prelimbic cortex (U= 6, P= 0.032), except for
the cingulate cortex area 1 and 2 (all Uo16, P40.253), ventral
orbital cortex (t11 =− 0.009, P= 0.993), lateral orbital cortex (t11
= 0.656, P= 0.525), and infralimbic cortex (U= 11, P= 0.571). No
signiﬁcant effects were found in both the NAc core and shell parts
(all Uo19, P40.475). In the habenula, there was an increase of
c-Fos-ir cells in the lateral part (t10 = 2.573, P= 0.042), and not the
medial part of habenular nucleus (U= 12, P= 0.584). In the
hippocampus, activation of c-Fos-ir cells was shown in the
hippocampal CA1 (t10 = 2.573, P= 0.028) and CA3 (t10 = 2.483,
P= 0.032) ﬁelds, but not the hippocampal dentate gyrus (t9
= 0.047, P= 0.964). In the amygdala, vmPFC HFS speciﬁcally
activated the c-Fos-ir expression in the lateral (t10 = 2.772,
P= 0.020) and basolateral (t10 = 2.269, P= 0.047) amygdaloid
nucleus. No difference was detected in the medial (t10 = 0.361,
P= 0.725) and central (t10 = 1.732, P= 0.114) amygdaloid nucleus.
In the hypothalamus, there was an activation of c-Fos-ir expression
in the anterior (t8 = 3.258, P= 0.012) and dorsomedial (t8 = 2.314,
Figure 2. A set of bar graphs showing the measures of anxiety-like behavior by home-cage emergence (a and b) and open-ﬁeld (c and d) tests
in naive animal experiments. Before testing, animals were stimulated for 15min and continuously for another 5min during both the anxiety
tasks. LFS of the LHb, and HFS of the Cg, vmPFC, NAc core and LHb reduced the escape latency from the home-cage emergence test,
indicating anxiolytic behavior. No signiﬁcant difference was found in the open-ﬁeld test of both LFS and HFS groups. Data represent
means± s.e.m. Signiﬁcant difference from the sham animals, *Po0.05. Cg, cingulate cortex; HFS, high-frequency stimulation; LFS, low-
frequency stimulation; LHb, lateral habenular nucleus; NAc, nucleus accumbens; vmPFC, ventromedial prefrontal cortex.
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Figure 3. A set of bar graphs showing the measures of food motivation by food intake test (a and b), levels of anhedonia by sucrose intake
test (c and d) and forced-swim behavior test (e–j) in naive animal experiments. Before testing, animals were stimulated for 15min and
continuously for 2 h in the food intake test, 1 h in the sucrose intake test and 10min in the forced-swim test. HFS of the Cg, vmPFC, NAc core
and LHb signiﬁcantly increased the levels of motivation for food intake. No signiﬁcant difference was found in the sucrose intake and forced-
swim behaviors of both LFS and HFS groups, as well as the food intake test of LFS group. Data represent means± s.e.m. Signiﬁcant difference
from the sham animals, (*Po0.05). Cg, cingulate cortex; HFS, high-frequency stimulation; LFS, low-frequency stimulation; LHb, lateral
habenular nucleus; NAc, nucleus accumbens; vmPFC, ventromedial prefrontal cortex.
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P= 0.049) hypothalamus, and the medial parvicellular part of the
paraventricular hypothalamic nucleus (t9 = 2.569, P= 0.030). How-
ever, there was no signiﬁcant change of c-Fos expression found in
the posterior (t10 = 1.571, P= 0.147), medial (t10 = 0.804, P= 0.440)
and perifornical nucleus of the hypothalamus (t9 = 1.517,
P= 0.164), as well as the lateral magnocellular part of the
paraventricular hypothalamic nucleus (t8 = 1.305, P= 0.228). In
the periaqueductal gray, no signiﬁcant difference was found in all
regions of both the anterior and posterior parts (t114− 0.574,
P40.274).
Interestingly, we found a decrease of c-Fos expression in the
deep cerebellar nucleus of the magnocelluar part of the
interposed cebebellar nucleus (t10 =− 2.234, P= 0.049). No sig-
niﬁcant differences were found in the dentate nucleus of
cerebellum (t11 =− 1.175, P= 0.265), parvicelluar part of the
interposed cebebellar nucleus (t11 =− 0.427, P= 0.678), fastigial
cerebellar nucleus (t11 =− 1.180, P= 0.263), parvicellular part of the
medial vestibular nucleus (t11 =− 0.894, P= 0.391), magnocellular
part of the medial vestibular nucleus (t11 =− 0.798, P= 0.442) and
the spinal vestibular nucleus (t11 =− 0.935, P= 0.370).
Figure 4. A set of bar graphs showing the measures of anxiety-like behavior by home-cage emergence (a) and open-ﬁeld (b) tests, food
motivation by food intake test (c), measures of anhedonia by sucrose intake test (d) and the forced-swim behavior test (e–g) after HFS in the
CUS rat model of depression. Animals were similarly stimulated and tested as in the naive animal experiment. Note: HFS of the vmPFC, NAc
core, and the LHb reduced anxiety-like behavior in the home-cage emergence test. However, in the open-ﬁeld and sucrose intake tests,
vmPFC HFS, but not other DBS targets, signiﬁcantly increased time spent of rats in the open-ﬁeld center zone and increased sucrose intake,
indicating anxiolytic and alleviation of anhedonic-like behavior as compared with CUS sham rats. Finally, both the LHb and vmPFC HFS
reduced forced-swim immobility. Data represent means± s.e.m. Signiﬁcant difference from the CUS sham animals, *Po0.05; signiﬁcant
difference from the non-CUS control animals, #Po0.05. CUS, chronic unpredictable stress; DBS, deep brain stimulation; HFS, high-frequency
stimulation; LHb, lateral habenular nucleus; NAc, nucleus accumbens; vmPFC, ventromedial prefrontal cortex.
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DISCUSSION
DBS is a potential therapy for patients with major depression.
Different brain targets have been explored and different outcomes
have been obtained with respect to depressive-like symptoms.
Here, we compared the depressive-like behavioral outputs of DBS
of different brain areas in naive animals and a model of
depression. Our results in the naive animals revealed that HFS,
but not LFS, of the Cg, vmPFC, NAc core and LHb reduced anxiety
levels, as indicated by shorter escape latency and an increased
motivation for food consumption. No signiﬁcant difference of DBS
was detected in the open-ﬁeld, sucrose intake and forced-swim
tests, as compared with the sham.
The features of clinical depression include symptoms of
emotional instability (low mood, anxiety), anhedonia, poor
motivation, fatigue and hopelessness.22 Our present CUS
model produced a robust behavioral phenotype. After 3 weeks
of consecutive stress, animals displayed elevated levels of
anxiety, increased latency when escaping from the home-cage
and decreased time spent in the open-ﬁeld center zone when
compared with nonstressed controls. In addition, there was also a
Figure 5. Effects of vmPFC HFS on DRN neuronal ﬁring. (a) Excitatory and inhibitory effects on putative 5-HT DRN neurons (n= 18) ﬁring rate
changes before, during and after vmPFC HFS. Darkened zone area indicates stimulation period (100 Hz, 100 μA, 100 μs). Firing rate was
quantiﬁed during the ﬁnal 60 s before stimulation as control baseline, during the second and ﬁfth minute of vmPFC HFS, and on the ﬁfth
minute following cessation of vmPFC stimulation. Note, both excitatory and inhibitory effects on the ﬁring rates of 5-HT neurons were
observed by vmPFC HFS. (b) Photomicrographs showing immunohistochemical characterization of a neurobiotin (NB) juxtacellular-labeled 5-
HT immunopositive neuron in the rat DRN. Scale bar, 20 μm at × 40 magniﬁcation. (c) A triphasic extracellular waveform shape with a broad
spike width typically used to indicate for 5-HT neuron. (d and f) Spike trains and mean ﬁring rate (15-s bins) of 5-HT putative neurons, before,
during and after 5 min HFS of the vmPFC. Darkened zone areas indicate stimulation period (second and ﬁfth minute of vmPFC HFS). Plot of
percentage excitation (e) and inhibition (g) during the ﬁfth minute after vmPFC HFS against baseline ﬁring rates. Signiﬁcant difference from
the baseline levels *Po0.05. 5-HT, 5-hydroxytryptamine, serotonin; DRN, dorsal raphe nucleus; HFS, high-frequency stimulation; vmPFC,
ventromedial prefrontal cortex.
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decrease of sucrose consumption and an increased immobility
time in the forced-swim test of the CUS sham animals,
suggesting anhedonia and behavioral despair.41 Our results show
that HFS of the vmPFC, NAc Core and LHb reduced anxiety
in the home-cage emergence test. However, in the open-ﬁeld and
sucrose intake tests, only vmPFC HFS, but not other targets,
resulted in major improvements in terms of anxiety and increased
sucrose consumption, indicating a reduction of anhedonic-like
behavior, one of the core symptoms of depression.42,43 In the
forced-swim test, HFS of the vmPFC and LHb signiﬁcantly reduced
immobility time as compared with CUS sham. Taken together,
our behavioral ﬁndings identify the vmPFC as a speciﬁc and
potent structure to relieve depressive-like symptoms by HFS when
compared with other stimulated targets. HFS of the NAc core and
Figure 6. Effects of vmPFC HFS on the c-Fos neural activity (a) and the percentage changes of mean gray value on 5-HT positive cells (c) in the
DRN region of CUS animal model of depression. Representative photomicrographs of c-Fos (b; scale bar, 500 μm at × 4 magniﬁcation) and 5-
HT (d; scale bar, 50 μm at × 40 magniﬁcation) histochemical staining of 30-μm-thick sections in the DRN. Note, vmPFC HFS resulted in higher
levels of neuronal activation (that is, increased c-Fos positive cells) in the DRN areas as compared with the CUS sham animals. The small dots
represent c-Fos-ir cells per mm2. Meanwhile, vmPFC HFS caused a remarkable reduction of optical density of 5-HT containing cells in the DRN
area, indicating a local release of 5-HT, which increases in extracellular 5-HT in the DRN and forebrain projection areas. Representative high-
power confocal images (e) are shown for the localization of 5-HT (red; e-i and -ii) and c-Fos (green; e-iii) immunoﬂuorescence positive cells.
DAPI (blue; e-v) was used as a nuclear stain. Merged images demonstrated the co-localization (arrows) of 5-HT and c-Fos (e-iv), as well as
counterstained with DAPI (e-vi) in the DRD. Dotted arrows demonstrated non-c-Fos 5-HT positive cells (e-iv and -vi). Scale bar for ﬂuorescent
images: 100 μm (e-i) at low-power magniﬁcation; and 20 μm (e-ii–vi) at × 100 magniﬁcation. Signiﬁcant difference from the CUS sham animals,
*Po0.05. 5-HT, 5-hydroxytryptamine, serotonin; Aq, aqueduct; CUS, chronic unpredictable stress; DAPI, 4',6-diamidino-2-phenylindole; DRN,
dorsal raphe nucleus dorsal part; DRV, dorsal raphe nucleus ventral part; DRVL, dorsal raphe nucleus ventrolateral part; HFS, high-frequency
stimulation; vmPFC, ventromedial prefrontal cortex.
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LHb showed partial effects on the depressive-like behavioral
outputs.
The present DBS study in naive animals was used to determine
which brain targets and which stimulation paradigms (either LFS
or HFS) were the most effective for antidepressant activities. Our
data clearly showed that HFS of the Cg, vmPFC, NAc core and LHb
results in improvements to both anxiety and motivation for food
intake. However, no changes in DBS effects were found in the
Table 1. Effects of vmPFC HFS on c-Fos-ir expression in brain regions implicated in the pathophysiology of depression
Brain regions Subregion HFS vmPFC (CUS) SHAM (CUS) P-value
Mean ± SEM Mean ± SEM
Frontal cortex Cg1 162.90 71.98 78.67 21.85 P= 0.475
Cg 2 162.09 92.83 52.07 14.79 P= 0.253
VO 380.93 87.34 382.16 102.36 P= 0.993
LO 449.34 75.89 345.48 147.13 P= 0.525
PrL 267.64 109.68 94.11 18.07 P=0.032
IL 146.35 85.79 87.22 25.37 P= 0.571
Nucleus accumbens NAc core 80.57 44.03 36.13 10.99 P= 0.475
NAc shell 106.16 63.94 53.73 12.60 P= 0.775
Habenula MHb 3.93 0.93 6.07 3.41 P= 0.584
LHb 68.94 18.24 15.87 9.62 P=0.042
Hippocampus CA1 199.25 52.31 50.78 24.37 P=0.028
CA3 146.70 25.19 59.25 24.60 P=0.032
DG 200.23 42.12 196.32 77.25 P= 0.964
Amygdala MeA 153.95 31.92 140.90 16.88 P= 0.725
CeA 108.66 25.90 56.48 15.39 P= 0.114
LA 168.26 24.94 78.35 20.74 P=0.020
BLA 113.93 12.61 76.02 10.97 P=0.047
Hypothalamus DMH 284.27 43.68 174.60 18.40 P=0.049
PeFLH 205.34 25.82 161.05 6.83 P= 0.164
AH 100.23 18.96 34.36 7.02 P=0.012
PH 264.27 27.73 191.70 36.94 P= 0.147
VMH 148.86 26.46 118.81 26.40 P= 0.440
PaMP 157.11 35.45 52.53 12.22 P=0.030
PaLM 195.39 45.09 107.26 47.09 P= 0.228
Anterior periaqueductal gray dmPAG 78.26 9.30 67.60 18.23 P= 0.597
dlPAG 92.36 15.25 73.42 19.93 P= 0.459
lPAG 154.58 19.20 119.19 24.57 P= 0.274
vlPAG 127.01 19.51 114.97 38.24 P= 0.775
Posterior periaqueductal gray dmPAG 136.07 14.06 116.16 21.82 P= 0.446
dlPAG 111.43 12.95 110.03 22.74 P= 0.956
lPAG 142.78 11.66 146.59 27.23 P= 0.894
vlPAG 153.17 15.65 171.02 28.34 P= 0.578
Deep cerebellar nuclei Dent 92.03 13.79 107.68 3.76 P= 0.265
IntMC 81.56 6.05 118.03 12.95 P=0.049
IntPC 113.39 28.10 126.04 13.37 P= 0.678
Fast 44.39 11.87 59.85 6.66 P= 0.263
Vestibular nuclei MVePC 20.70 3.38 26.00 4.65 P= 0.391
MVeMC 25.40 4.45 30.53 4.58 P= 0.442
SpVe 60.85 7.95 68.80 4.00 P= 0.370
Dorsal raphe nucleus DRD 34.11 4.94 21.74 2.06 P=0.034
DRV 18.80 5.28 17.03 3.39 P= 0.686
DRVL 41.86 2.49 23.07 1.22 P=0.001
Abbreviations: AH, anterior hypothalamus; BLA, basolateral amygdaloid nucleus; CA1, hippocampal CA1 ﬁeld; CA3, hippocampal CA3 ﬁeld; CeA, central
amygdaloid nucleus; Cg1, dorsal cingulate cortex area 1; Cg2, dorsal cingulate cortex area 2; Dent, dentate nucleus of cerebellum; DG, dentate gyrus; DMH,
dorsomedial hypothalamus; dlPAG, dorsolateral periaqueductal gray; dmPAG, dorsomedial periaqueductal gray; DRD, dorsal raphe nucleus, dorsal part; DRV, dorsal
raphe nucleus, ventral part; DRVL, dorsal raphe nucleus, ventrolateral part; Fast, fastigial cerebellar nucleus; IL, infralimbic cortex; IntMC, interposed cebebellar
nucleus, magnocelluar part; IntPC, interposed cebebellar nucleus, parvicelluar part; LA, lateral amygdaloid nucleus; LHb, lateral habenular nucleus; LO, lateral orbital
cortex; lPAG, lateral periaqueductal gray; MeA, medial amygdaloid nucleus; MHb, medial habenular nucleus; MVeMC, medial vestibular nucleus, magnocellular part;
MVePC, medial vestibular nucleus, parvicellular part; NAc core, nucleus accumbens core; NAc shell, nucleus accumbens shell; PaLM, paraventricular hypothalamic
nucleus, lateral magnocellular; PaMP, paraventricular hypothalamic nucleus, medial parvicellular; PeFLH, perifornical nucleus of the hypothalamus; PH, posterior
hypothalamus; PrL, prelimbic cortex; SpVe, spinal vestibular nucleus; vlPAG, ventrolateral periaqueductal gray; VMH, ventromedial hypothalamus; VO, ventral orbital
cortex. Before being killed, animals received 1 h stimulation and 1 h interval in their home-cage to determine the peak level of nuclear protein c-Fos-ir expression.
Note, a remarkable increase of c-Fos neuronal activation was detected in the vmPFC (PrL), LHb, hippocampus (CA1, CA3), amygdala (LA, BLA), hypothalamus
(DMH, AH, PaMP) and DRN (DRD, DRVL). Interestingly, there was a decrease of c-Fos expression found in the deep cerebellar nucleus (IntMC). Data represent
means± s.e.m. of c-Fos-ir cells per mm2. P-value o0.05 (in bold) indicates statistically signiﬁcant difference from the Sham CUS animals.
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open-ﬁeld, sucrose intake and forced-swim tests. These ﬁndings
were partially consistent with the results of Hamani et al.,44 which
showed that HFS (at amplitude 100 and 200 μA), but not LFS of
the vmPFC induced antidepressant response in the forced-swim
test of naive animals. Although we found no difference in terms of
stimulation effects on the forced-swim behaviors, it is important to
highlight here that we compared the effects across different brain
targets using the more stringent Bonferroni post hoc test to avoid
false positives. In addition, when the individual DBS target(s) in
our study was analyzed and compared with sham animals
independently, there were signiﬁcant stimulation effects found
on the behavioral paradigms (see Supplementary Tables 1 and 2).
However, the main purpose of our study was to compare across
different DBS targets and determine which brain target(s) elicited
the most optimal behavioral outcomes. Thus, the statistical
analyses were conducted using Bonferroni post hoc tests to
provide adequate protection against increased error rates in
multiple comparisons. An alternative explanation for the non-
signiﬁcant effects found in the open-ﬁeld, sucrose intake and
forced-swim tests, is that they could be due to a nonpathological
depressive condition in naive animals.36 As our results clearly
demonstrated a signiﬁcance difference of behavioral phenotypes
between CUS and non-CUS naive animals, we therefore tested our
hypothesis in this validated CUS animal model35,36 using
previously determined brain targets and stimulation parameters
that were derived from the naive animal study.
Interestingly, in a comparison of all stimulated targets, we
found that HFS of the vmPFC produced the most profound
antidepressant effects with reduced anxiety, decreased anhedonia
and forced-swim immobility in the CUS model. Although HFS of
the LHb counteracted the CUS-induced changes in the home-cage
emergence escape latency and forced-swim immobility, NAc core
HFS only normalized its escape latency. To evaluate the
physiological impact of DBS on these targets, it has been shown
that vmPFC HFS (at 100/200 μA, 130 Hz and 90 μs) increased the
hippocampal 5-HT release (fourfold increase) and brain-derived
neurotrophic factor levels in the CUS rats,13,14 with signiﬁcant
contribution to antidepressant-like effects. Similarly, LHb stimula-
tion (at 15 Hz, 500 μA) produced a 55–70% increase in striatal 5-HT
release, and its stimulation at 1.5–3 Hz induced no detectable
changes in striatal extracellular 5-HT levels.45 Further, stimulation
(at 100 μA, 130 Hz and 100 μs) of the dorsal–ventral striatum (NAc
core), but not ventral–ventral striatum (part of NAc shell) increased
neuronal brain-derived neurotrophic factor in the mPFC region.46
A further study also showed that NAc core HFS (at 300 μA, 120 Hz
and 80 μs) enhanced 5-HT levels in the mPFC with ~ 27% increase
compared with baseline.47 In contrast, our previous ﬁndings found
no stimulation effects on the 5-HT levels in the mPFC structure
with respect to both NAc core and NAc shell stimulation (at 30 μA,
130 Hz and 60 μs),48 and we also demonstrated that NAc shell, but
not NAc core, HFS increased 5-HT levels in the NAc region. Despite
these controversial ﬁndings on NAc stimulation, the effects of DBS
depend largely on speciﬁc stimulation parameters, in which HFS
and optimum amplitude have an important role for
antidepressant-like effects. In the present study, although we
did not examine the 5-HT levels in our comparison of these
stimulated targets, it is still worth noting that vmPFC HFS was
found to be the best target for antidepressant effects behaviorally.
This notion is highly supported by previous studies, which show
that vmPFC HFS produced fourfold of hippocampal 5-HT
extracellular release, while LHb and NAc core stimulation
produced ~ 55–70% and 27% increase of 5-HT levels in the
forebrain region as compared with baseline, respectively.45,47
As vmPFC HFS has been identiﬁed as the most optimal target
for antidepressant-like response, we further looked into its
functional role in the neurocircuitry of depressive-like behavior.
The vmPFC has a pivotal role in modulating sadness and negative
emotions in both depressed and healthy subjects.8,49 It has
predominant reciprocal connections with the limbic brain areas
that are involved in emotions and reward processes, including the
amygdala, hippocampus, hypothalamus and midbrain.50,51 In this
study, HFS of the vmPFC evoked a widespread, but selective,
modulation of these brain areas. Our anatomical mapping study
showed that HFS of the vmPFC modulated the cellular activity in
speciﬁc areas within the vmPFC (prelimbic area), LHb, hippocam-
pus (CA1 and CA3 regions), lateral and basolateral amygdaloid
nucleus, anterior and dorsomedial hypothalamus and the medial
parvicellular part of the paraventricular hypothalamic nucleus.
There was also a decreased c-Fos expression in the deep
cerebellar nucleus of the magnocelluar part of the interposed
cerebellar nucleus. Interestingly, no signiﬁcant difference was
found in the periaqueductal gray, a region known to be involved
in the expression of fear and defensive behavior.25 Our ﬁndings
suggest that HFS of the vmPFC modulated a brain circuit, which is
crucial for the regulation of emotions implicated in depression.
This is in line with clinical studies of individuals with depression
showing changes of brain volume and function in the amygdala,
hippocampus and PFC.52,53 Converging evidence from clinical and
animal studies have also demonstrated that depression is not a
single brain region disorder, but a multisystem disorder affecting
the cortico–limbic pathway as well as the midbrain regions. For
review, see Franklin et al.54
In clinical research, functional neuroimaging studies have
demonstrated that hypoactivation observed in the vmPFC is
closely associated with patients suffering from posttraumatic
stress disorder.55,56 Similarly, such hypoactivity or abnormality in
the subgenual prefrontal cortex has also been found in depressed
patients53,57 or individuals with childhood emotional
maltreatment.58 This is consistent with animal models showing
lower neural activity or decreased immediate early gene expres-
sion in the mPFC structure following stress exposure (for instance
social defeat, predator stress or water submersion).11,59 In the
present study, we showed the beneﬁcial effect of antidepressant
activity with reversal of this hypoactivity by HFS of the vmPFC. In
line with our observation, various methods of stimulation by
optogenetic or transcranial magnetic stimulation have also
induced signiﬁcant improvement on behavioral outcome by
rescuing the hypofunction of the vmPFC.60,61 Importantly, DBS
induced striking changes in these brain regions with reversal of
abnormal cerebral blood ﬂow and glucose metabolism leading to
sustained mood improvement in case series of depressed
patients.8
The vmPFC, including ventral prelimbic and infralimbic
regions, regulates not only emotion and memory functions,62
but also autonomic and neuroendocrine responses in stressful
conditions.63,64 In anatomical and functional connectivity, the
vmPFC has reciprocal connections with the hypothalamus, which
mediates the neuroendocrine function in response to stress
through activation of the hypothalamic–pituitary–adrenal axis by
stimulation of the neurons in the medial parvicellular part of the
paraventricular hypothalamic nucleus.54 In addition, the hippo-
campus also has direct or indirect projections to the paraven-
tricular hypothalamic nucleus, which negatively regulates the
hypothalamic–pituitary–adrenal axis function. In this study, vmPFC
HFS induced remarkable c-Fos neuronal activity within the
hippocampal regions and paraventricular hypothalamic nucleus,
indicating a regulatory role of the vmPFC in modulating stress
response through the hippocampus–hypothalamic–pituitary–
adrenal axis pathway. The connection of vmPFC–hippocampus is
mainly by way of direct projection from the hippocampal CA1 and
subiculum to the prelimbic, infralimbic and medial orbital areas.65
On the other hand, the projection of vmPFC to the hippocampus
is via the nucleus reunions that function as a relay for the
convergence of limbic-related information from widespread
regions.66 This implies an involvement of the limbic–thalamo–
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cortical circuits in emotional control for depression, as previously
proposed.57,67
In the cerebellum, it has been demonstrated that patients with
cognitive impairments had reduced metabolic activity (cerebral
blood ﬂow) in the vmPFC and increased activity in the
cerebellum.68 Functional imaging studies also showed that the
increased activity in the cerebellum is highly correlated with
emotional instability such as sadness, feeling empathy and
viewing emotional pictures.69,70 Importantly, the cerebellum has
robust anatomical connections to the limbic system.71–73 One
recent study using retrograde transneuronal transport of the
rabies virus has identiﬁed a connection of the deep cerebellar
nuclei—more speciﬁcally, the interpositus nucleus projects to the
prefrontal cortex via the thalamus.74 In line with previous studies,
our present results show decreased c-Fos expression in the
magnocellular part of the interposed cerebellar nucleus by vmPFC
HFS, suggesting a role for the cerebro–thalamo–cortical pathway.
The vmPFC has strong reciprocal connections with a wide range
of structures including the amygdala, habenula and a number of
brain stem nuclei implicated in the regulation of mood and
anxiety disorders.64 Many studies have established a speciﬁc
amygdala–frontal circuit for the control, expression and experi-
ence of negative emotions.75,76 Furthermore, the interaction
between vmPFC and LHb has imposed a primary cortico–
hebenular pathway.18,77 There is also strong evidence supporting
the LHb–DRN interaction which assigns the LHb a major role in 5-
HT regulation and its neurotransmitter release from the DRN to
the forebrain.78,79 The pattern of c-Fos expression in the present
study showed that HFS of the vmPFC inﬂuences the neuronal
circuit for depressive-like behaviors, which is likely to be mediated
in the DRN. A potential mediator of this effect could be the
midbrain 5-HT system, which is known to project to the key areas
involved in emotions, as mentioned above.80,81 With HFS of the
vmPFC, we found a profound and speciﬁc modulation of DRN
neurons, the major source of 5-HT to the forebrain, shown both
electrophysiologically and histochemically. The neurochemical
effect would be an enhanced release of 5-HT in the target areas.
This has been previously demonstrated.14,44
Although immediate early genes (such as c-Fos) are not a
ubiquitous marker for studying connectivity, they have been
widely used in DBS studies in animal models of mood and anxiety
disorders.28,82 In a recent study, vmPFC HFS induced a profound
increase of Zif268 expression, another immediate early gene, in
the prelimblic cortical region.82 This is in line with our ﬁndings.
Our electrophysiological recordings showed an effect of vmPFC
stimulation on neuronal activity in the DRN. We found that vmPFC
HFS induced either excitation (39%) or inhibition (61%) of cell
ﬁring in the 5-HT neurons tested. Meanwhile, non-5-HT neurons
showed either inhibition (19%) or were nonresponsive to vmPFC
HFS. The main ﬁndings were that vmPFC HFS evoked a speciﬁc
modulation of both the 5-HT and non-5-HT cell ﬁring. This is in
accordance with previous evidence showing that DRN inputs from
the prefrontal cortex are able to inﬂuence the neuronal ﬁring rate
by either directly activating the DRN 5-HT neurons or by local
GABAergic interneurons.81,83 Moreover, earlier work has also
suggested reciprocal actions of 5-HT and GABA, demonstrating
GABA inhibitory inputs to the DRN 5-HT neurons,84,85 contributing
to the inhibition of 5-HT cell ﬁring.
The ﬁring rate of a 5-HT neuron is commonly the determinant of
5-HT neurotransmission and function in a terminal region.86 It has
been shown that bilateral subthalamic nucleus HFS caused a
moderate inhibition of 5-HT cell ﬁring in the DRN, which evoked
clear-cut, depressive-like behavior in the forced-swim test.29 In the
present study, one would assume that this inhibition of 5-HT cell
ﬁring might possibly be linked to depressive-like effects, as in the
case of subthalamic nuclear stimulation. Nevertheless, it is
important to note that the behavioral effects obtained from
subthalamic nucleus and vmPFC HFS were completely opposite to
this. Although we showed ~ 61% inhibition of cell ﬁring in the 5-
HT neurons with vmPFC HFS, our stimulation elicited antidepres-
sant activity. This is further supported by microdialysis studies in
which subthalamic nucleus HFS reduced extracellular 5-HT,87,88
whereas vmPFC HFS enhanced its 5-HT release in speciﬁc
forebrain regions.14,44,89 One plausible explanation of the inhibi-
tory effect is that it is due to the mechanisms of autoinhibition of
5-HT cells caused by endogenous local release of 5-HT from
activated or neighboring cells.90,91 This could also be achieved by
5-HT1A autoreceptor-mediated feedback inhibition of 5-HT cells
that are found on the dendrites and cell bodies of these
neurons.90,92 Another possible explanation is that such an
inhibitory effect on 5-HT ﬁring rate can result from GABA–5-HT
interaction. This has been demonstrated by intra-DRN adminis-
tration of GABA antagonists that enhanced 5-HT cell ﬁring and
release,93,94 and eventually inhibited 5-HT cell ﬁring by the
autoinhibition mechanism.
In conclusion, we found that HFS of the vmPFC produced
promising antidepressant effects with enhanced hedonia and
decreased anxiety and forced-swim immobility in the CUS animal
model. This effect was accompanied by modulation of a number
of key regions involved in emotional processing by a DRN-
dependent mechanism. Overall, our ﬁndings identify the vmPFC
as a speciﬁc and potent modulator of depressive-like behaviors,
and as a favorable target for DBS in refractory depression.
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